We applied ANG-2–targeted treatment in combination with a monoclonal anti–PD-1 targeting antibody and VEGFR inhibitor (Vatalanib) in autochthonous SCLC mice (Figure 9A). Here, KDR is linked to small cell lung carcinoma.